Patents Assigned to Brien Holden Vision Institute
-
Patent number: 10203522Abstract: The present disclosure is directed to lenses, devices, methods and/or systems for addressing refractive error. Certain embodiments are directed to changing or controlling the wavefront of the light entering a human eye. The lenses, devices, methods and/or systems can be used for correcting, addressing, mitigating or treating refractive errors and provide excellent vision at distances encompassing far to near without significant ghosting. The refractive error may for example arise from myopia, hyperopia, or presbyopia with or without astigmatism. Certain disclosed embodiments of lenses, devices and/or methods include embodiments that address foveal and/or peripheral vision. Exemplary of lenses in the fields of certain embodiments include contact lenses, corneal onlays, corneal inlays, and lenses for intraocular devices both anterior and posterior chamber, accommodating intraocular lenses, electro-active spectacle lenses and/or refractive surgery.Type: GrantFiled: November 21, 2016Date of Patent: February 12, 2019Assignee: Brien Holden Vision InstituteInventors: Ravi Chandra Bakaraju, Klaus Ehrmann, Arthur Ho, Brien Anthony Holden
-
Patent number: 10191301Abstract: Contact lenses are described with a corneal remodelling effect. This corneal remodelling effect is one or both of broad-area corneal remodelling and localized remodelling. The contact lenses may also have a refractive power. The refractive power may vary across the lens and for myopia may have increased power centrally. The increased power may be provided over a lens area that has increased thickness due to localized remodelling.Type: GrantFiled: December 14, 2016Date of Patent: January 29, 2019Assignee: Brien Holden Vision InstituteInventors: Arthur Ho, Padmaja Rajagopal Sankaridurg, Brien Anthony Holden, Percy Fabian Lazon, Xiang Chen, Fabian Conrad, Earl Leo Smith
-
Patent number: 10191300Abstract: The present disclosure is directed to lens, methods of making, designing lens and/or methods using lens in which performance may be improved by providing one or more steps in the central portion of the optical zone and one or more steps in the peripheral portion of the optic zone. In some embodiments, such lens may be useful for correcting refractive error of an eye and/or for controlling eye growth.Type: GrantFiled: December 10, 2013Date of Patent: January 29, 2019Assignee: Brien Holden Vision InstituteInventors: Brien Anthony Holden, Padmaja Rajagopal Sankaridurg, Klaus Ehrmann, Fabian Conrad, Arthur Ho
-
Patent number: 10182716Abstract: A method for evaluating retinal function and testing the visual field of a patient by monitoring how the patient tracks a target image on a display that comprises displaying the target image on the display such that it is located at a first position on the display and visible to the patient. The process continues by identifying what portion of the display the patient is looking at, selecting a location of the patient's retina to test, and calculating, based at least in part on what portion of the display the patient is looking at, a second position on the display corresponding to the selected location of the patient's retina. The target image is displayed at the second position on the display and the process identifies how many eye movements the patient made to look at the target at the second position. Based at least in part on the number of eye movements, the process determines whether the patient was able to see the target at the second position.Type: GrantFiled: August 19, 2015Date of Patent: January 22, 2019Assignee: Brien Holden Vision InstituteInventors: Tom N. Cornsweet, Paul Peterson, Brad Bower
-
Patent number: 10175392Abstract: An optical processor is presented for applying optical processing to a light field passing through a predetermined imaging lens unit. The optical processor comprises a pattern in the form of spaced apart regions of different optical properties. The pattern is configured to define a phase coder, and a dispersion profile coder. The phase coder affects profiles of Through Focus Modulation Transfer Function (TFMTF) for different wavelength components of the light field in accordance with a predetermined profile of an extended depth of focusing to be obtained by the imaging lens unit. The dispersion profile coder is configured in accordance with the imaging lens unit and the predetermined profile of the extended depth of focusing to provide a predetermined overlapping between said TFMTF profiles within said predetermined profile of the extended depth of focusing.Type: GrantFiled: August 31, 2015Date of Patent: January 8, 2019Assignee: Brien Holden Vision InstituteInventors: Zeev Zalevsky, Alex Zlotnik, Ido Raveh, Shai Ben-Yaish, Ofer Limon, Oren Yehezkel, Karen Lahav
-
Patent number: 10156737Abstract: Sets, kits or stocks of anti-myopia lenses and methods for their use, that do not require a clinician to measure peripheral refractive error in the eyes of myopic patients. Lenses having peripheral powers or defocus set in accordance with central corrective power will cover almost all normal myopes not worse than ?6D central refractive error. For example, a kit or set of lenses (50, FIG. 15) can have multiple parts or sub-sets each with a compartmented container with lenses arranged according to increments of central corrective power. The lenses of the first part have four steps of peripheral power or defocus to provide therapeutic effect and, while the lenses of the second part also have four steps, the level of therapeutic effect is higher. Other examples of sets, kits and stocks, as well as examples of lenses themselves, are disclosed together with methods of use.Type: GrantFiled: January 26, 2017Date of Patent: December 18, 2018Assignees: Novartis AG, Brien Holden Vision InstituteInventors: Aldo Abraham Martinez, Arthur Ho, Padmaja Rajagopal Sankaridurg, Percy Fabian Lazon, Brien Anthony Holden, Rick Payor, Gregor F. Schmid
-
Patent number: 10085960Abstract: The invention relates to compositions and devices which include an osmolytic agent, in particular a betaine or carnitine compound, for reducing ocular discomfort associated with various diseases or conditions, in particular diseases or conditions associated with high tear film tonicity. The invention also relates to methods of treating or preventing various diseases or conditions using compositions and devices of the invention.Type: GrantFiled: March 28, 2013Date of Patent: October 2, 2018Assignee: Brien Holden Vision InstituteInventor: Qian Garrett
-
Patent number: 10078159Abstract: An imaging lens structure and method of imaging are presented. The imaging lens structure comprising a lens region defining an effective aperture of the lens structure. The lens region comprises an arrangement of lens zones distributed within the lens region and comprising zones of at least two different optical functions differently affecting light passing therethrough. The zones of at least two different optical functions are arranged in an interlaced fashion along said lens region corresponding to a surface relief of the lens region such that adjacent lens zones of different optical functions are spaced apart from one another along an optical axis of the lens structure a distance larger than a coherence length of light at least one spectral range for which said lens structure is designed.Type: GrantFiled: January 4, 2016Date of Patent: September 18, 2018Assignee: Brien Holden Vision InstituteInventors: Zeev Zalevsky, Alex Zlotnik, Shai Ben-Yaish, Ofer Limon, Ido Raveh
-
Patent number: 10031334Abstract: A phase-adjusting element configured to provide substantially liquid-invariant extended depth of field for an associated optical lens. One example of a lens incorporating the phase-adjusting element includes the lens having surface with a modulated relief defining a plurality of regions including a first region and a second region, the first region having a depth relative to the second region, and a plurality of nanostructures formed in the first region. The depth of the first region and a spacing between adjacent nanostructures of the plurality of nanostructures is selected to provide a selected average index of refraction of the first region, and the spacing between adjacent nanostructures of the plurality of nanostructures is sufficiently small that the first region does not substantially diffract visible light.Type: GrantFiled: February 9, 2011Date of Patent: July 24, 2018Assignee: Brien Holden Vision InstituteInventors: Zeev Zalevsky, Ofer Limon
-
Patent number: 10004714Abstract: The present disclosure relates to compositions, methods and devices for treating, reducing or preventing one or more eye disorders, particularly dry eye disorders, in a subject by administering an amount of one or more fatty acids and/or fatty acid esters therapeutically effective to inhibit lipase activity while permitting bacterial growth or without substantially altering the dynamic microbial community of the eye. Typically, the fatty acids and/or fatty acid esters are C8 to C16 fatty acids and/or fatty acid esters.Type: GrantFiled: July 9, 2013Date of Patent: June 26, 2018Assignee: Brien Holden Vision InstituteInventors: Hua Zhu, Judith Louise Flanagan
-
Patent number: 9936867Abstract: Described herein is a light directing assembly for use in an object analysis system. The light directing assembly includes a plurality of optical relay assemblies. Each optical relay assembly includes at least one optical element configured to relay an interrogation beam from a light transmission system to an object and relay a return beam from the object to the light transmission system, the return beam being generated by reflection or back scattering of the interrogation beam by the object. Each optical relay assembly defines an interrogation angle at which the interrogation beam relayed by the optical relay assembly reaches the object, and an optical path length being the distance from the light transmission system to the object traveled by an interrogation beam via the optical relay assembly.Type: GrantFiled: August 18, 2016Date of Patent: April 10, 2018Assignee: Brien Holden Vision InstituteInventors: Klaus Ehrmann, Darrin Mark Falk, Cathleen Fedtke
-
Patent number: 9936869Abstract: An ocular fundus camera system and an associated methodology. The system includes (a) an image sensor disposed along a fundus-image reflection path adjacent that path's downstream end, and in optical communication with light carried in this path, (b) an aperture centered on the reflection path's long axis, operatively associated with, and stationary with respect to, the sensor at a location which is upstream from the sensor, and (c), for accomplishing (1) precision fundus-image focusing on the sensor, and additionally (2) autorefraction, optical, light-content shifting structure, operable selectively for producing, within that portion of the reflection path which is disposed downstream from the shifting structure, relative trans-axial displacement solely of any non-collimated light carried in that portion of the main path which is disposed upstream from the shifting structure.Type: GrantFiled: January 18, 2017Date of Patent: April 10, 2018Assignee: Brien Holden Vision InstituteInventors: Tom N. Cornsweet, Paul R. Peterson
-
Publication number: 20170336653Abstract: A corrective lens system for the eyes of an individual includes first and second pairs of lenses of first and second prescriptions, respectively. In certain embodiments, the first pair of lenses includes a first lens for the left eye and a first lens for the right eye, and the second pair of lenses includes a second lens for the left eye and a second lens for the right eye. The first and second pairs of lenses may be configured in package having a plurality of compartments with individual lenses disposed in individual compartments. A set of instructions may be provided for wearing the first pair of lenses for a first time period and the second pair of lenses for a second time period. The first prescription is different from the second prescription. The lenses may inhibit the progression of myopia in the individual. Methods of arranging, prescribing, and using the lens system are described.Type: ApplicationFiled: November 4, 2015Publication date: November 23, 2017Applicant: Brien Holden Vision InstituteInventor: Ravi Chandra Bakaraju
-
Publication number: 20170322110Abstract: A method for assessing the similarity between a power profile of a manufactured optic device and a nominal power profile upon which the power profile of the manufactured optic device is based. The method comprises measuring the power profile of manufactured optic device, identifying a region of interest from the measured power profile of manufactured optic device, and applying an offset to the measured power profile to substantially minimize a statistical quantifier for quantifying the similarity between the nominal power profile and the offset measured power profile. The method further comprises comparing the offset and the statistical quantifier to predefined quality control metrics, determining whether the measured power profile meets the predefined quality control metrics based, at least in part on the comparison.Type: ApplicationFiled: November 11, 2015Publication date: November 9, 2017Applicant: Brien Holden Vision InstituteInventors: Fabian Conrad, Ravi Chandra Bakaraju, Klaus Ehrmann
-
Patent number: 9759930Abstract: The present disclosure is directed to lenses, devices, methods and/or systems for addressing refractive error. Certain embodiments are directed to changing or controlling the wavefront of the light entering a human eye. The lenses, devices, methods and/or systems can be used for correcting, addressing, mitigating or treating refractive errors and provide excellent vision at distances encompassing far to near without significant ghosting. The refractive error may for example arise from myopia, hyperopia, or presbyopia with or without astigmatism. Certain disclosed embodiments of lenses, devices and/or methods include embodiments that address foveal and/or peripheral vision. Exemplary of lenses in the fields of certain embodiments include contact lenses, corneal onlays, corneal inlays, and lenses for intraocular devices both anterior and posterior chamber, accommodating intraocular lenses, electro-active spectacle lenses and/or refractive surgery.Type: GrantFiled: October 15, 2015Date of Patent: September 12, 2017Assignee: Brien Holden Vision InstituteInventors: Ravi Chandra Bakaraju, Klaus Ehrmann, Arthur Ho, Brien Anthony Holden
-
Patent number: 9594257Abstract: Sets, kits or stocks of anti-myopia contact or spectacle lenses, along with methods for their use, that do not require a clinician to measure peripheral refractive error in the eyes of myopic patients. Extensive surveys have shown that lenses having peripheral powers or defocus set in accordance with central corrective power will cover almost all normal myopes not worse than ?6D central refractive error. In one example, a kit or set of lenses (50, FIG. 15) can have multiple parts or sub-sets (52, 54) each comprising a compartmented container (56a, 56b) with lenses (58a, 58b) arranged according to increments of central corrective power (59a, 59b). The lenses (58a) of the first part (52) have four steps (60a, 61a, 62a, 64a) of peripheral power or defocus to provide therapeutic effect and, while the lenses (58b) of the second part (54) also have four steps (60b, 61b, 62b, 64b), the level of therapeutic effect is higher.Type: GrantFiled: January 21, 2014Date of Patent: March 14, 2017Assignees: Novartis AG, Brien Holden Vision InstituteInventors: Aldo Abraham Martinez, Arthur Ho, Padmaja Rajagopal Sankaridurg, Percy Fabian Lazon, Brien Anthony Holden, Rick Payor, Gregor F. Schmid
-
Patent number: 9575334Abstract: Certain embodiments are directed to lenses, devices and/or methods. For example, a lens for an eye having an optical axis and an aberration profile along its optical axis, the aberration profile having a focal distance and including higher order aberrations having at least one of a primary spherical aberration component C(4,0) and a secondary spherical aberration component C(6,0). The aberration profile may provide, for a model eye with no aberrations and an on-axis length equal to the focal distance: (i) a peak, first retinal image quality (RIQ) within a through focus range that remains at or above a second RIQ over the through focus range that includes said focal distance, where the first RIQ is at least 0.35, the second RIQ is at least 0.1 and the through focus range is at least 1.8 Diopters; (ii) a RIQ of 0.3 with a through focus slope that improves in a direction of eye growth; and (iii) a RIQ of 0.3 with a through focus slope that degrades in a direction of eye growth.Type: GrantFiled: December 9, 2014Date of Patent: February 21, 2017Assignee: Brien Holden Vision InstituteInventors: Ravi Chandra Bakaraju, Klaus Ehrmann, Arthur Ho
-
Patent number: 9551884Abstract: Contact lenses are described with a corneal remodelling effect. This corneal remodelling effect is one or both of broad-area corneal remodelling and localised remodelling. The contact lenses may also have a refractive power. The refractive power may vary across the lens and for myopia may have increased power centrally. The increased power may be provided over a lens area that has increased thickness due to localised remodelling.Type: GrantFiled: February 24, 2015Date of Patent: January 24, 2017Assignee: Brien Holden Vision InstituteInventors: Arthur Ho, Padmaja Rajagopal Sankaridurg, Brien Anthony Holden, Percy Fabian Lazon, Xiang Chen, Fabian Conrad, Earl Leo Smith, III
-
Patent number: 9541773Abstract: The present disclosure is directed to lenses, devices, methods and/or systems for addressing refractive error. Certain embodiments are directed to changing or controlling the wavefront of the light entering a human eye. The lenses, devices, methods and/or systems can be used for correcting, addressing, mitigating or treating refractive errors and provide excellent vision at distances encompassing far to near without significant ghosting. The refractive error may for example arise from myopia, hyperopia, or presbyopia with or without astigmatism. Certain disclosed embodiments of lenses, devices and/or methods include embodiments that address foveal and/or peripheral vision. Exemplary of lenses in the fields of certain embodiments include contact lenses, corneal onlays, corneal inlays, and lenses for intraocular devices both anterior and posterior chamber, accommodating intraocular lenses, electro-active spectacle lenses and/or refractive surgery.Type: GrantFiled: October 4, 2013Date of Patent: January 10, 2017Assignee: Brien Holden Vision InstituteInventors: Ravi Chandra Bakaraju, Klaus Ehrmann, Arthur Ho, Brien Anthony Holden
-
Patent number: 9535263Abstract: The present disclosure is directed to lenses, devices, methods and/or systems for addressing refractive error. Certain embodiments are directed to changing or controlling the wavefront of the light entering a human eye. The lenses, devices, methods and/or systems can be used for correcting, addressing, mitigating or treating refractive errors and provide excellent vision at distances encompassing far to near without significant ghosting. The refractive error may for example arise from myopia, hyperopia, or presbyopia with or without astigmatism. Certain disclosed embodiments of lenses, devices and/or methods include embodiments that address foveal and/or peripheral vision. Exemplary of lenses in the fields of certain embodiments include contact lenses, corneal onlays, corneal inlays, and lenses for intraocular devices both anterior and posterior chamber, accommodating intraocular lenses, electro-active spectacle lenses and/or refractive surgery.Type: GrantFiled: April 5, 2013Date of Patent: January 3, 2017Assignee: Brien Holden Vision InstituteInventors: Ravi Chandra Bakaraju, Klaus Ehrmann, Arthur Ho, Brien Anthony Holden